Literature DB >> 23764710

Blue toe syndrome as a complication of intra-arterial chemotherapy for retinoblastoma.

Ahmet Sarici, Osman Kizilkilic, Tiraje Celkan, Safa Gode.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23764710     DOI： 10.1001/jamaophthalmol.2013.1458

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  5 in total

1.  Toe necrosis: report of uncommon aetiology.

Authors:  Siham Mansouri; Ayoub Bounsir; Laila Benzekri; Badr Hassam
Journal:  BMJ Case Rep       Date:  2019-07-12

2.  Toe Necrosis, Etiologies and Management, a Case Series.

Authors:  Abdelfatah Abou Issa; Mackenzie Newman; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2014-09-28

3.  An alternative technique of the superselective catheterization of the ophthalmic artery for intra-arterial chemotherapy of the retinoblastoma: retrograde approach through the posterior communicating artery to the ophthalmic artery.

Authors:  Muzaffer Saglam; Ahmet Sarici; Vania Anagnostakou; Bulent Yildiz; Naci Kocer; Civan Islak; Osman Kizilkilic
Journal:  Neuroradiology       Date:  2014-06-10       Impact factor: 2.804

Review 4.  Risk definition and management strategies in retinoblastoma: current perspectives.

Authors:  Fariba Ghassemi; Alireza Khodabande
Journal:  Clin Ophthalmol       Date:  2015-06-08

5.  Antitumor effect of Quercetin on Y79 retinoblastoma cells via activation of JNK and p38 MAPK pathways.

Authors:  Haojie Liu; Ming Zhou
Journal:  BMC Complement Altern Med       Date:  2017-12-13       Impact factor: 3.659
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.